NEW YORK (GenomeWeb News) – Monsanto said today that it will open a research center in Beijing that will focus on collaborations with Chinese research institutions in plant biotechnology and genomics research.

The agricultural biotech firm said that the Monsanto Biotechnology Research Center in Zhongquancun will conduct early-stage genomics and bioinformatics research and it will be the base for collaborations with Chinese scientists.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.